7096 — StemCell Institute Income Statement

0.000.00%

Last trade - 00:00

HealthcareMicro CapFalling Star

Annual income statement for StemCell Institute, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,782	2,091	2,481	2,679	2,811
Cost of Revenue
Gross Profit	1,111	1,336	1,576	1,692	1,712
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,555	1,815	2,066	2,261	2,609
Operating Profit	227	276	415	419	202
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	213	279	441	566	218
Provision for Income Taxes
Net Income After Taxes	134	198	311	386	131
Minority Interest
Net Income Before Extraordinary Items
Net Income	134	198	311	386	156
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	134	198	311	386	156
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	13.1	20.8	30.2	37.7	15.4
Dividends per Share
Special Dividends per Share